Summary
Profit after tax climbed more than 2% to US$2.5 billion in the three months to the end of June, compared with the same period last year.
AstraZeneca’s Q2 net profit rises on strong cancer drug sales
Source & full coverage: this summary is aggregated from Free Malaysia Today Business, the original publisher. Read the complete report for full context, data and quotes.
Read the original report at Free Malaysia Today Business →
